Abstract Library

#4654 Usefulness of soluble tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and its receptors R2 and R3 in progression assessment of gastroenteropancreatic neuroendocrine neoplasms – A preliminary study

Introduction: TRAIL is a member of TNF family and appears in membrane and soluble (s) forms. It acts either triggering (R1 and R2) or blocking (R3 and R4) apoptosis. TRAIL targeted therapy is widely studied and known as potentially effective in number of neoplasms.

Conference:

Presenting Author: Kaczmarska-Turek D

Authors: Kaczmarska-Turek D, Radziszewski M, Matałowski M, Liszcz A, Bartoszewicz Z,

Keywords: gastroenteropancreatic neuroendocrine neoplasm, tumour necrosis factor-related apoptosis-inducing ligand, tumour progression, PRRT, TRAIL, GEP-NEN,

#4631 Correlations between dosimetry and imaging in patients with neuroendocrine tumour treated with 177Lu-DOTATATE

Introduction: Tumour dose may be an important predictor of clinical response, but estimation of a clinically relevant tumour-absorbed dose without high risk of toxicity is challenging.

Conference:

Presenting Author: Gomez Sanchez D

Authors: Gomez Sanchez D, Ribelles M, Fernandez Iglesias A, Paruta Araez L, Mata E,

Keywords: dosimetry, 177Lu-DOTATATE,

#4170 Analysis of the efficacy of STEM chemotherapy in patients with metastatic paraganglioma

Introduction: Paraganglioma is a special kind of neuroendocrine tumor, located outside the adrenal gland, about 35-40% is related to heredity and has corresponding germline mutation. The therapeutic response is different from that of neuroendocrine tumors derived from gastrointestinal and pancreas.

Conference:

Presenting Author: Tan H

Authors: Tan H, Zhao H, Shi S, Jiang L, Chi Y,

Keywords: metastatic paraganglioma, STEM, efficacy,

#3973 Clinical value of endoscopic submucosal dissection combined with chemotherapy for treatment of esophageal neuroendocrine carcinoma

Introduction: Due to the lack of large-scale data describing the clinical and pathological characteristics of esophageal neuroendocrine carcinoma（eNEC), there is no standardized diagnosis and treatment of eNEC currently.

Conference:

Presenting Author:

Authors: Na H, Qi T,

Keywords: Esophageal neuroendocrine carcinoma, Endoscopic submucosal dissection, Chemotherapy,

#3678 Complete remission of Necrolytic Migratory Erythema related to glucagonoma under octreotide therapy

Introduction: Glucagonomas are rare neuroendocrine tumors (NETs), generally diagnosed with locoregional involvement; it has heterogeneous survival with therapeutic approaches ranging from the use of somatostatin analogues, and cytoreductive surgery to PRRT.

Conference:

Presenting Author:

Authors: González Devia D, Rozo-Paz G, Chalela-Mantilla J, Aguirre Matallana D, Arias Amézquita F,

Keywords: Glucagonoma, Migratory necrolytic erythema, Octreotide, Overall survival, Neuroendocrine tumor,